Braidwell LP Trans Medics Group, Inc. Transaction History

Braidwell LP

$1.73 Billion
Q3 2025

A detailed history of Braidwell LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Braidwell LP holds 351,248 shares of TMDX stock, worth $40.4 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares

351,248

Previous 255,048 37.72%

Holding current value

$40.4 Million

Previous $34.2 Million 15.31%

% of portfolio

2.27%

Previous 2.09%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$103.61 - $132.04 $9.97 Million - $12.7 Million	96,200 Added 37.72%	351,248 $39.4 Million
Q2 2025 Aug 14, 2025	SELL	$67.67 - $143.04 $40.6 Million - $85.8 Million	-599,836 Reduced 70.17%	255,048 $34.2 Million
Q1 2025 May 15, 2025	SELL	$56.73 - $79.42 $3.81 Million - $5.34 Million	-67,216 Reduced 7.29%	854,884 $57.5 Million
Q4 2024 Feb 14, 2025	BUY	$59.28 - $144.9 $54.7 Million - $134 Million	922,100 New	922,100 $57.5 Million
Q2 2024 Aug 14, 2024	SELL	$72.62 - $150.62 $30.8 Million - $63.9 Million	-424,571 Reduced 69.09%	189,960 $28.6 Billion

Q1 2024 May 15, 2024	BUY	$70.86 - $89.93 $35.2 Million - $44.7 Million	496,830 Added 422.11%	614,531 $45.4 Billion
Q4 2023 Feb 14, 2024	SELL	$36.74 - $81.08 $6.96 Million - $15.4 Million	-189,499 Reduced 61.69%	117,701 $9.29 Billion
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $16.4 Million - $29.5 Million	307,200 New	307,200 $16.8 Billion
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $11 Million - $16.9 Million	-204,726 Reduced 67.53%	98,459 $7.46 Billion
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $11.8 Million - $19.5 Million	303,185 New	303,185 $18.7 Billion

Others Institutions Holding TMDX

# of Institutions

438

Shares Held

30.4M

Call Options Held

1.01M

Put Options Held

928K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.66B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.

Account